SIGMAPHARM
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Jul 2022)
What this means for you
This application is over — abandoned 18 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87943198
- Mark type
- Stylized text
- Filed
- 31 May 2018
- Published for opposition
- 23 Oct 2018
- Abandoned
- 18 Jul 2022
- Attorney of record
- Susan M. Schlesinger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of atherosclerosis
- Class 042 — Scientific and technological services: Research and development of pharmaceutical products and preparations for the treatment of atherosclerosis
Owner
- SigmaPharm Laboratories, LLC, Bensalem, PA, US
- SigmaPharm Laboratories, LLC, Bensalem, PA, US
Prior registrations
Prosecution history
- 18 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Dec 2021 — SOU EXTENSION 5 GRANTED
- 13 Dec 2021 — SOU EXTENSION 5 FILED
- 21 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 08 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2021 — SOU EXTENSION 4 GRANTED
- 04 Jun 2021 — SOU EXTENSION 4 FILED
- 04 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 10 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2020 — SOU EXTENSION 3 GRANTED
- 06 Nov 2020 — SOU EXTENSION 3 FILED
- 06 Nov 2020 — SOU TEAS EXTENSION RECEIVED